Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Hedner

Showing results (11-20 of 242) with videos related to

Pageof 25
Sort By:
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 13, 2000
NovoSeven as a universal haemostatic agentU Hedner
Thrombosis Et Diathesis Haemorrhagica|December 15, 1975
Urinary fibrin/fibrinogen derivativesU Hedner
Thrombosis Et Diathesis Haemorrhagica|November 1, 1973
Studies on an inhibitor of plasminogen activation in human serumU Hedner
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 1, 1990
Factor VIIa in the treatment of haemophiliaU Hedner
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|November 18, 1998
Recombinant activated factor VII as a universal haemostatic agentU Hedner
Vox Sanguinis|June 24, 2004
Recombinant FVIIaU Hedner
Thrombosis Et Diathesis Haemorrhagica|April 30, 1975
Letter: Platelet aggregating properties of Ehlers-Danlos syndrome "collagen"U Hedner
Seminars in Hematology|December 6, 2001
Recombinant factor VIIa (Novoseven) as a hemostatic agentU Hedner
Advances in Experimental Medicine and Biology|September 14, 2001
Use of high dose factor VIIa in hemophilia patientsU Hedner
Seminars in Thrombosis and Hemostasis|September 30, 2000
Development of tinzaparin: a heparinase-digested low-molecular-weight heparinU Hedner
Pageof 25

Showing results (11-20 of 242) with videos related to

Sort By:
Pageof 25
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|June 13, 2000
NovoSeven as a universal haemostatic agentU Hedner
Thrombosis Et Diathesis Haemorrhagica|December 15, 1975
Urinary fibrin/fibrinogen derivativesU Hedner
Thrombosis Et Diathesis Haemorrhagica|November 1, 1973
Studies on an inhibitor of plasminogen activation in human serumU Hedner
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 1, 1990
Factor VIIa in the treatment of haemophiliaU Hedner
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|November 18, 1998
Recombinant activated factor VII as a universal haemostatic agentU Hedner
Vox Sanguinis|June 24, 2004
Recombinant FVIIaU Hedner
Thrombosis Et Diathesis Haemorrhagica|April 30, 1975
Letter: Platelet aggregating properties of Ehlers-Danlos syndrome "collagen"U Hedner
Seminars in Hematology|December 6, 2001
Recombinant factor VIIa (Novoseven) as a hemostatic agentU Hedner
Advances in Experimental Medicine and Biology|September 14, 2001
Use of high dose factor VIIa in hemophilia patientsU Hedner
Seminars in Thrombosis and Hemostasis|September 30, 2000
Development of tinzaparin: a heparinase-digested low-molecular-weight heparinU Hedner
Pageof 25